aTYR PHARMA INC Short-term Investments
aTYR PHARMA INC (ATYR) had Short-term Investments of $79.00 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2025-11-06
- 2025-09-30: Short-term Investments $79.00M.
- 2016-03-31: Short-term Investments $31.95M.
- 2015-12-31: Short-term Investments $42.51M.
- 2015-09-30: Short-term Investments $48.75M.
| Period end | Short-term Investments |
|---|---|
| 2025-09-30 | $79.00M 10-Q · filed 2025-11-06 |
| 2016-03-31 | $31.95M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $42.51M 10-Q · filed 2016-05-11 |
| 2015-09-30 | $48.75M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $39.89M 10-Q · filed 2015-08-12 |
| 2014-12-31 | $1.95M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |